Publication | Closed Access

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing

Neuro-oncologyGliomaTumor HeterogeneityNtrk FusionsMedicinePathologyCancer GenomicsSitu HybridisationMolecular PathologyHigh-grade GliomasMolecular DiagnosticsScreening ToolCancer BiologyCell BiologyTumor Biology